Lumosa Therapeutics Co., Ltd.
Clinical trials sponsored by Lumosa Therapeutics Co., Ltd., explained in plain language.
-
New stroke drug shows promise in safety trial
Disease control CompletedThis study tested whether a new drug called LT3001 is safe and effective for treating recent ischemic strokes. The trial involved 89 patients who received either the drug or a placebo within 24 hours of stroke symptoms starting. Researchers compared safety outcomes and how well p…
Phase: PHASE2 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New stroke drug tested for safety and brain bleeding risk
Disease control CompletedThis study tested a new drug called LT3001 for people who recently had an ischemic stroke (caused by a blocked blood vessel in the brain). The main goal was to check if the drug is safe and doesn't cause dangerous bleeding in the brain, compared to a placebo. It involved 24 patie…
Phase: PHASE2 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
One-shot pain relief tested for post-surgery recovery
Symptom relief CompletedThis study tested whether a single, long-acting pain injection given before surgery could help manage pain for people recovering from hemorrhoid removal. It involved 221 adults who were scheduled for this surgery. Researchers compared the injection to a placebo (a dummy shot) to …
Phase: PHASE2, PHASE3 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
First human tests begin for new stroke treatment
Knowledge-focused CompletedThis early-stage study tested the safety of an experimental drug called LT3001, which is being developed for acute ischemic stroke. Researchers gave the drug to 65 healthy volunteers to check for side effects and see how it interacts with common blood-thinning medications like as…
Phase: PHASE1 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 18, 2026 18:25 UTC